Login/Sign Up
Daclacruz 60 mg Tablet 28's
Daclacruz 60 mg Tablet 28's is used to treat Hepatitis C virus infection. It contains Daclatasvir, which works by blocking the activity of the hepatitis C virus in the liver cells. This causes viral DNA termination and reduces the amount of hepatitis C virus in the body. Common side effects of Daclacruz 60 mg Tablet 28's include headache, fatigue, weakness, confusion, chest pain, nausea, diarrhoea, shortness of breath, dizziness and lightheadedness.
₹6000*
₹5100*
MRP ₹6000
15% CB
₹900 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Daclacruz 60 mg Tablet 28's is an antiviral medicine used along with sofosbuvir, with or without ribavirin, to treat chronic hepatitis C viral genotype 1 or 3 infection. It is a serious infection caused by the hepatitis C virus. It is a contagious infection that spreads from person to person and affects the liver. Daclacruz 60 mg Tablet 28's is only used in treating the infection. It does not cure or prevent further liver complications.
Daclacruz 60 mg Tablet 28's contains Daclatasvir, which belongs to the class of hepatitis C virus (HCV) NS5A inhibitors. It works by blocking the activity of the hepatitis C virus in the liver cells. This causes viral DNA termination and reduces the amount of hepatitis C virus in the body.
Daclacruz 60 mg Tablet 28's may cause certain side effects such as headache, fatigue, weakness, confusion, chest pain, nausea, diarrhoea, shortness of breath, dizziness and lightheadedness. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor. Use it as suggested by your doctor. Your doctor will decide the duration of the medicine based on your health condition.
Daclacruz 60 mg Tablet 28's should be avoided if you are allergic to it. If you are pregnant or breastfeeding, inform your doctor before starting treatment with this medicine. Daclacruz 60 mg Tablet 28's is not recommended for children below 18 years of age as efficacy and safety have not been established. Inform your doctor if you have any underlying conditions like hepatitis B virus infection, liver cirrhosis, nephrotoxicity, liver transplant, heart problem, kidney problems, or HIV infection, as it may cause serious side effects. Daclacruz 60 mg Tablet 28's may cause hepatitis B infection reactivation and bradycardia (slow heart rate) in some patients. Hence, patients should be monitored carefully for any changes.
Daclacruz 60 mg Tablet 28's contains Daclatasvir, which belongs to the class of hepatitis C virus (HCV) NS5A inhibitors. It works by blocking the activity of the hepatitis C virus in the liver cells. This causes viral DNA termination and, therefore, reduces the amount of hepatitis C virus in the body.
Daclacruz 60 mg Tablet 28's should be avoided if you are allergic to it. If you are pregnant or breastfeeding, inform your doctor before starting treatment with this medicine. Daclacruz 60 mg Tablet 28's is not recommended for children below 18 years of age as efficacy and safety have not been established. Inform your doctor if you have any underlying conditions like hepatitis B virus infection, liver cirrhosis, nephrotoxicity, liver transplant, heart problem, other kidney problems, or HIV infection, as it may cause serious side effects. Daclacruz 60 mg Tablet 28's may cause hepatitis B infection reactivation and bradycardia in some patients. Hence, patients should be monitored carefully for any changes.
Drug-Drug Interactions: Daclacruz 60 mg Tablet 28's may interact with a antifungal drugs (ketoconazole, voriconazole), antibiotics (clarithromycin, telithromycin), cholesterol-lowering medicines (atorvastatin, pitavastatin), narcotic analgesics (buprenorphine, naloxone), antiviral drugs (atazanavir, nelfinavir, indinavir), antiarrhythmic drug (amiodarone), anticoagulant drugs (dabigatran, warfarin), CYP3A inducers (phenytoin, carbamazepine, phenobarbitone, rifampin).
Drug-Food Interactions: No interactions found.
Drug-Disease Interactions: Inform your doctor if you have any history of liver or kidney disease or HIV/AIDS infection.
Hepatitis C Virus Infection: It is a contagious infection caused by the hepatitis C virus affecting the liver. This infection spreads from person to person through blood contact (being pricked with a contaminated needle or using a razor), intimate contact with the infected person, direct contact with infected blood, or contact with any other personal items with leftovers of infected fluid or even from mother to baby during birth. The symptoms may not appear immediately. Some may take between 2 to 12 weeks to appear. Few people may have mild to moderate symptoms such as dark urine, loss of appetite, fever, joint pain, or stomach discomfort. The complications of untreated chronic hepatitis C include liver cancer or liver cirrhosis (scarring).
Alcohol
Consult your doctor
It is not known if Daclacruz 60 mg Tablet 28's interacts with alcohol. Please consult your doctor.
Pregnancy
Caution
If you are pregnant or planning pregnancy, inform your doctor before taking Daclacruz 60 mg Tablet 28's. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
Caution
If you are a nursing mother, inform your doctor before taking Daclacruz 60 mg Tablet 28's. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Driving
Consult your doctor
It is not known if Daclacruz 60 mg Tablet 28's affects your ability to drive. Do not drive or operate heavy machinery if you are not alert.
Liver
Caution
If you have a history of liver disease, inform your doctor before taking Daclacruz 60 mg Tablet 28's. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Kidney
Caution
If you have a history of kidney disease, inform your doctor before taking Daclacruz 60 mg Tablet 28's. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Children
Unsafe
Daclacruz 60 mg Tablet 28's is not recommended for use in children below 18 years of age, as efficacy and safety have not been established.
Country of origin
Manufacturer/Marketer address
Product Substitutes